Press Releases

Hogan Lovells Advises on Groundbreaking FDA Grant of De Novo Request to Market a Novel Artificial Intelligence-based Device

Philadelphia / San Francisco, 16 April 2018 – IDx LLC, with assistance from Hogan Lovells, achieved a major grant of De Novo classification from the U.S. Food and Drug Administration...

Press Releases

Senior FDA Official Joins Hogan Lovells

WASHINGTON DC, 25 May 2016 – Hogan Lovells announced today that Dr. Herbert Lerner, former Deputy Director of the Division of Reproductive, Gastro-Renal and Urological Devices at the ...

Loading data